Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

FDA approves drug that doubles survival for advanced pancreatic cancer

The US FDA has approved daraxonrasib for metastatic pancreatic cancer after trials showed it doubled survival compared to chemotherapy.

FDA approves drug that doubles survival for advanced pancreatic cancer

We haven't written up this one. Ajel English has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at english.ajel.sa →

More in Health & Medicine

More from Monday 31 August →